Monica Shalini Krishnan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiation Oncology | 6 | 2017 | 507 | 0.880 |
Why?
|
Palliative Care | 15 | 2022 | 3261 | 0.740 |
Why?
|
Life Expectancy | 3 | 2013 | 1116 | 0.700 |
Why?
|
Bone Neoplasms | 4 | 2018 | 2579 | 0.470 |
Why?
|
Pain | 4 | 2022 | 4636 | 0.370 |
Why?
|
Neoplasms | 11 | 2022 | 20172 | 0.350 |
Why?
|
Radiosurgery | 1 | 2018 | 1352 | 0.350 |
Why?
|
Lymph Node Excision | 1 | 2013 | 1179 | 0.310 |
Why?
|
Decision Making | 2 | 2021 | 3802 | 0.250 |
Why?
|
Karnofsky Performance Status | 1 | 2020 | 186 | 0.190 |
Why?
|
Neoplasm Metastasis | 5 | 2019 | 5112 | 0.190 |
Why?
|
Clinical Clerkship | 2 | 2015 | 511 | 0.180 |
Why?
|
Models, Statistical | 1 | 2013 | 5034 | 0.170 |
Why?
|
Goals | 1 | 2022 | 642 | 0.160 |
Why?
|
Internship and Residency | 1 | 2017 | 5556 | 0.160 |
Why?
|
Lymphopenia | 1 | 2018 | 285 | 0.150 |
Why?
|
Radiotherapy | 3 | 2018 | 1623 | 0.140 |
Why?
|
Cisplatin | 1 | 2021 | 1651 | 0.130 |
Why?
|
Critical Pathways | 1 | 2017 | 460 | 0.130 |
Why?
|
Lung Neoplasms | 3 | 2022 | 12183 | 0.110 |
Why?
|
Axilla | 1 | 2013 | 534 | 0.100 |
Why?
|
Terminal Care | 2 | 2020 | 1632 | 0.100 |
Why?
|
Pain Measurement | 1 | 2020 | 3510 | 0.100 |
Why?
|
Advance Care Planning | 1 | 2017 | 611 | 0.100 |
Why?
|
Spinal Diseases | 1 | 2015 | 557 | 0.100 |
Why?
|
Qualitative Research | 3 | 2022 | 2506 | 0.090 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2013 | 654 | 0.090 |
Why?
|
Spinal Fractures | 1 | 2015 | 688 | 0.090 |
Why?
|
Joint Instability | 1 | 2015 | 748 | 0.080 |
Why?
|
Spinal Neoplasms | 1 | 2015 | 837 | 0.080 |
Why?
|
Career Choice | 1 | 2014 | 743 | 0.080 |
Why?
|
Brain Neoplasms | 2 | 2019 | 8776 | 0.080 |
Why?
|
Health Personnel | 1 | 2020 | 2983 | 0.070 |
Why?
|
Humans | 27 | 2022 | 708843 | 0.070 |
Why?
|
Program Evaluation | 1 | 2015 | 2524 | 0.070 |
Why?
|
Breast Neoplasms | 1 | 2013 | 19800 | 0.070 |
Why?
|
Students, Medical | 2 | 2015 | 1740 | 0.070 |
Why?
|
Prognosis | 5 | 2022 | 28919 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2016 | 3885 | 0.070 |
Why?
|
Nurses | 1 | 2013 | 2370 | 0.060 |
Why?
|
Curriculum | 2 | 2015 | 3329 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2021 | 11126 | 0.060 |
Why?
|
Female | 14 | 2021 | 375205 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2017 | 2910 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2013 | 2029 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2022 | 71483 | 0.050 |
Why?
|
Immunotherapy | 1 | 2017 | 4057 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2013 | 3409 | 0.050 |
Why?
|
Male | 13 | 2020 | 349524 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 3970 | 0.050 |
Why?
|
Middle Aged | 11 | 2021 | 213752 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2016 | 16008 | 0.050 |
Why?
|
Survival Analysis | 1 | 2013 | 10507 | 0.050 |
Why?
|
Physicians | 2 | 2017 | 4292 | 0.050 |
Why?
|
Computer Simulation | 1 | 2013 | 6048 | 0.050 |
Why?
|
Melanoma | 1 | 2017 | 5194 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 4865 | 0.040 |
Why?
|
Maximum Tolerated Dose | 1 | 2021 | 914 | 0.040 |
Why?
|
Death | 1 | 2022 | 573 | 0.040 |
Why?
|
Cultural Characteristics | 1 | 2019 | 263 | 0.040 |
Why?
|
Health Care Surveys | 2 | 2017 | 2502 | 0.040 |
Why?
|
Aged | 9 | 2021 | 161488 | 0.040 |
Why?
|
Hospices | 1 | 2020 | 237 | 0.040 |
Why?
|
Referral and Consultation | 2 | 2020 | 3436 | 0.040 |
Why?
|
Morals | 1 | 2019 | 263 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2021 | 8896 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2018 | 813 | 0.040 |
Why?
|
Mastectomy, Segmental | 1 | 2021 | 922 | 0.040 |
Why?
|
Prospective Studies | 4 | 2021 | 50597 | 0.030 |
Why?
|
Dermatitis | 1 | 2017 | 194 | 0.030 |
Why?
|
Spirituality | 1 | 2019 | 394 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2017 | 435 | 0.030 |
Why?
|
Spinal Cord Compression | 1 | 2015 | 223 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2019 | 933 | 0.030 |
Why?
|
Chicago | 1 | 2014 | 245 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2020 | 58184 | 0.030 |
Why?
|
Mastectomy | 1 | 2021 | 1680 | 0.030 |
Why?
|
United States | 2 | 2017 | 67165 | 0.030 |
Why?
|
Patient Participation | 1 | 2021 | 1447 | 0.030 |
Why?
|
Back Pain | 1 | 2015 | 544 | 0.030 |
Why?
|
Quality of Life | 2 | 2022 | 11594 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2015 | 61932 | 0.020 |
Why?
|
Boston | 2 | 2014 | 9402 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19423 | 0.020 |
Why?
|
Postoperative Period | 1 | 2015 | 1843 | 0.020 |
Why?
|
Hepatitis, Chronic | 1 | 1988 | 51 | 0.020 |
Why?
|
Colitis | 1 | 2017 | 1140 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2014 | 1156 | 0.020 |
Why?
|
Microsomes, Liver | 1 | 1988 | 188 | 0.020 |
Why?
|
Microsomes | 1 | 1988 | 273 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1715 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2015 | 2927 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2015 | 1296 | 0.020 |
Why?
|
Adult | 5 | 2021 | 211041 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2013 | 2920 | 0.020 |
Why?
|
Health Surveys | 1 | 2017 | 3994 | 0.020 |
Why?
|
Program Development | 1 | 2014 | 1328 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3455 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 3316 | 0.020 |
Why?
|
Risk Factors | 1 | 2013 | 69553 | 0.020 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1988 | 432 | 0.020 |
Why?
|
Neutrophils | 1 | 2018 | 3867 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7644 | 0.020 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2014 | 1568 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10566 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8712 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2013 | 4266 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4615 | 0.010 |
Why?
|
Hospitalization | 1 | 2015 | 9644 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 55940 | 0.010 |
Why?
|
Kidney | 1 | 1988 | 6888 | 0.010 |
Why?
|
Immunoblotting | 1 | 1988 | 1795 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1988 | 2673 | 0.000 |
Why?
|
Blotting, Western | 1 | 1988 | 5456 | 0.000 |
Why?
|
Autoantibodies | 1 | 1988 | 1976 | 0.000 |
Why?
|
Child | 1 | 1988 | 73636 | 0.000 |
Why?
|